Filing Flows › Companies › Mereo BioPharma Group › Report card
Mereo BioPharma Group earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate0 of 4 reports beat the EPS estimate
Mereo BioPharma Group (MREO) beat the analysts' EPS estimate in 0 of its last 4 reports (0%). Next report: Nov 9, 2026, analysts expect EPS −$0.01.
Beat rate0% of 4
Average surprise—
Next reportNov 9, 2026
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise |
|---|---|---|---|---|
| Q to Jun 2026 | Aug 11, 2026 | −$0.01 | −$0.01 | n/m |
| Q to Mar 2026 | May 12, 2026 | $0.00 | −$0.01 | n/m |
| Q to Dec 2025 | Mar 19, 2026 | −$0.01 | −$0.01 | n/m |
| Q to Sep 2025 | Nov 10, 2025 | −$0.00 | −$0.01 | n/m |
Estimates and reported EPS are the Street's adjusted figures. No daily prices are on file for these report days, so the stock's moves are not shown.
Charts
The next report: what to expect → Mereo BioPharma Group: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.